Malignant neoplasm of left testis, unspecified whether descended or undescended
ICD-10 C62.92 is a billable code used to indicate a diagnosis of malignant neoplasm of left testis, unspecified whether descended or undescended.
C62.92 refers to a malignant neoplasm located in the left testis, where the specific status of the testis (whether it is descended or undescended) is not specified. Testicular cancer is one of the most common malignancies in young men, typically affecting those aged 15 to 35. The most common histological type is germ cell tumors, which can be further classified into seminomas and non-seminomas. Symptoms may include a painless lump in the testis, swelling, or discomfort. Diagnosis is often confirmed through imaging studies such as ultrasound and serum tumor markers, including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG). The staging of testicular cancer is crucial for determining treatment options and prognosis, typically classified using the TNM system. Fertility considerations are significant, as treatment may impact sperm production and quality. Patients may be advised to consider sperm banking prior to treatment, especially if undergoing chemotherapy or radiation therapy.
Detailed clinical notes on physical examination findings, imaging results, and tumor marker levels.
Diagnosis and management of testicular masses, follow-up after orchiectomy, and treatment planning.
Ensure accurate documentation of the testicular status and staging to support coding.
Comprehensive treatment plans, including chemotherapy regimens and response assessments.
Management of advanced testicular cancer and coordination of multidisciplinary care.
Documenting the impact of treatment on fertility and potential referrals for sperm banking.
Used when a patient undergoes surgery for testicular cancer.
Operative report detailing the procedure and findings.
Urology specialists should ensure accurate coding based on surgical findings.
The descended or undescended status can influence treatment options and prognosis, as undescended testis is a known risk factor for testicular cancer.
